Sector: MedicalSOBM (OTCBB: SOBM)
Headlines
- Sinobiomed: The Next Big Thing in China
Sep 12, 2008 03:18 PM | SOBM
- Sinobiomed and the Biopharmaceutical Revolution
Sep 09, 2008 06:19 PM | CHBT, CPHI, DNA, SOBM
- The Week in Review: Earnings and Development
Aug 23, 2008 08:17 PM | SNN, SOBM
- Sinobiomed: Negative Financials; Vibrant Development Program
Aug 21, 2008 12:02 PM | SOBM
- Progress on Clinical Trials and Highly Successful Application of Patented Biotechnology Into Consumer Product Line
Aug 20, 2008 01:00 PM | SOBM
- The Week in Review: Company Profiles and Drug Advancement
Aug 03, 2008 01:20 PM | AL, CMPD, MRK, NOVA, SNY, SOBM
- Sinobiomed Takes in New Capital
Jul 31, 2008 04:55 PM | SOBM
- Sinobiomed to Start Phase II Malaria Vaccine Trial
May 18, 2008 05:11 PM | SOBM
- The Metrics of Growth in China Biopharma
May 17, 2008 05:13 PM | ALNY, CSKI, MDCO, SCR, SOBM, SSRX
- Sinobiomed Announces New Executive Team
Feb 17, 2009 08:50 AM | SOBM
- Dutton Associates Announces Investment Opinion: Sinobiomed Speculative Buy Rating In Update Coverage By Dutton Associates
Oct 22, 2008 10:27 AM | SOBM
- Sinobiomed Directors Confirm Hiring of New Chief Financial Officer
Oct 08, 2008 01:30 PM | SOBM
- Sinobiomed Hires New Director of Strategic Development
Sep 03, 2008 09:31 AM | SOBM
- Sinobiomed Retains CB Capital Partners As Financial Advisor to Maximize Shareholder Value
Aug 26, 2008 08:52 PM | SOBM
- Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value
Aug 26, 2008 01:15 PM | SOBM
- Sinobiomed Applies for Two Chinese Patents and One International Patent
Aug 21, 2008 09:31 AM | SOBM
- Sinobiomed Corporate Update
Aug 20, 2008 11:00 AM | SOBM
- Sinobiomed Hires New Chief Financial Officer
Aug 13, 2008 11:01 AM | SOBM
- Sinobiomed Secures New Funding to Spur Growth
Jul 30, 2008 11:13 AM | SOBM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
SOBM
|
Compare to S&P
|
| YTD |
48.00 %
|
22.49 %
|
| 4 Weeks |
-41.27 %
|
-41.90 %
|
| 12 Weeks |
-38.33 %
|
-41.86 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -0.01 %
|
|
EPS Growth in Last Year: -0.01 %
|
|
Sales Growth in Last Quarter: -17.14 %
|
|
Sales Growth in Last Quarter: -92.93 %
|
|
